Trump administration’s conscience rule blocked by judge

Amy Baxter | | Health Exec | Policy & Regulations
Judge bangs gavel

A federal judge has blocked a controversial rule from the Trump administration that would have allowed healthcare professionals to refuse to perform services that went against their beliefs.

The rule, which has been called the conscience rule, was finalized by HHS in May. It enabled doctors and other healthcare workers to refuse care for religious reasons, such as abortion services and other family planning services.

According to U.S. District Judge Paul Engelmayer, who issued his judgment Nov. 6, HHS overstepped its authority with the rule, NPR reported. The judgment stems from lawsuits against HHS, including by Planned Parenthood and others. Critics of the rule said it would lead to discrimination in the healthcare system. HHS did not comment on the ruling, citing the pending litigation.

See the full story below:

Judge Scraps 'Conscience' Rule Protecting Doctors Who Deny Care For Religious R…

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
10 signs AI is ‘eating the world (of venture capital)’
Mangione now faces federal charges, death penalty in murder of UHC CEO
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
DOJ sues CVS over unlawful opioid prescriptions and reimbursement

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.